ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2968

Interrater Reliability of Nailfold Capillaroscopy in Systemic Sclerosis Using Widefield Microscopy

Jessica K. Gordon1, Meng Zhang2, Shervin Assassi3, Elana J. Bernstein4, Robyn T. Domsic5, Faye N. Hant6, Monique E. Hinchcliff7, Dinesh Khanna8, Ami A. Shah9, Victoria K. Shanmugam10,11, Virginia D. Steen12 and Tracy M. Frech13, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Epidemiology and Biostatistics, Hospital for Special Surgery, New York, NY, 3Rheumatology, University of Texas Medical School at Houston, Houston, TX, 4Rheumatology, Columbia University College of Physicians & Surgeons, New York, NY, 5Medicine - Rheumatology, University of Pittsburgh, Pittsburgh, PA, 6Dept of Medicine, Medical University of South Carolina, Charleston, SC, 7Division of Rheumatology, Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 8Division of Rheumatology, University of Michigan, Ann Arbor, MI, 9Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 10Director, Division of Rheumatology, The George Washington University, Washington, DC, 11Division of Rheumatology, The George Washington University, Washington, DC, 12Rheumatology, Georgetown University Medical Center, Washington, DC, 13Div of Rheumatology, University of Utah, Salt Lake City, UT

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Clinical research methods, Diagnostic imaging, nailfold capillaroscopy, scleroderma and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The presence of nailfold capillary (NFC) abnormality is part of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis (SSc).  NFC findings include the presence of capillary dilation, hemorrhage, and neoangiogenesis, and it has been shown that these patterns have prognostic value.  Patients in the Prospective Registry of Early Systemic Sclerosis (PRESS) cohort (diffuse SSc patients with < 2 years disease duration) have NFC evaluation using widefield microscopy (WM) at eleven centers in the United States.  Our objective in this study was to assess the interrater agreement of the PRESS investigators assessment of NFC abnormalities by WM in order to ensure the quality of our data collection.

Methods:

Investigators from the PRESS registry assessed 26 cases of patients with SSc without macrovascular changes or significant hand contractures who had been photographed using WM. The PRESS Investigators have attended training exercises to learn the capillaroscopic techniques, but no specific training was provided prior to this exercise.  Each case was assessed for NFC dilation, hemorrhage, and neoangiogenesis (defined as bushy capillaries) and rated as normal, mild, moderate, or severe for each of these categories.  Data were captured via surveymonkey and analyzed in two ways: 1.) using all 4 categorical variables and 2.) using a simplified approach where the variables were collapsed to normal vs abnormal.  Krippendorf’s alpha reliability estimate was used to assess the interrater agreement between these categorical variables.  The following values represent the following degrees of agreement: <0 – poor; 0-0.2 – slight; 0.21- 0.4 – fair; 0.41- 0.6 – moderate; 0.61-0.8 – substantial; and 0.81-1.0 – almost perfect agreement.

Results:

Intrarater reliability ranged from substantial to almost perfect agreement for NFC hemorrhage to substantial agreement for dilation of NFC loops to fair agreement for neoangiogenesis.  Assessment with four variables showed improved agreement when compared to 2 variables.  Results are presented in Table 1.   

Interrater Reliability

 

4 variables (normal, mild, moderate, severe)

2 variables (normal/abnormal)

NFC Hemorrhage – alpha (95% CI)

0.7991   (0.7528, 0.8403)

0.8205   (0.6801, 0.9262)

Dilated Capillary Loops – alpha (95% CI)

0.6538   (0.5930, 0.7093)

0.4869   (0.2846, 0.6934)

Neoangiogenesis – alpha (95% CI)

0.3738   (0.2820, 0.4644)

0.2706   (0.0879, 0.4527)

Table 1.  Krippendorf’s alpha reliability estimate using 4 variables (normal, mild, moderate, severe) and using 2 variables for the 3 categories of NFC abnormality assessed. 

Conclusion:

Fair inter-rater reliability was observed for neoangiogenesis, moderate to substantial reliability was observed for dilated capillary loops, and substantial to near perfect agreement was noted for reading of WM photomicrographs for NFC hemorrhage among PRESS investigators.  This attests to quality data collection for this procedure.  Classification of specific NFC abnormalities using the terms normal, mild, moderate, and severe is feasible and can be used reliably in registries.  Whether NFC abnormalities carry prognostic significance in patients with early diffuse SSc is a subject for future study in the PRESS registry.


Disclosure: J. K. Gordon, Bayer, 5; M. Zhang, None; S. Assassi, Biogen Idec, 5,Boehringer Ingelheim, 5; E. J. Bernstein, None; R. T. Domsic, Biogen-Idec, 5,Bayer, 5; F. N. Hant, None; M. E. Hinchcliff, None; D. Khanna, Bristol-Myers Squibb, 2,EMD Serono, 2,Genentech and Biogen IDEC Inc., 2,Bayer, 5,Biogen Idec, 5,Cytori, 5,EMD Serono, 5,Forward, 5,Genentech and Biogen IDEC Inc., 5,Gilead, 5,Lycera, 5,Seattle Genetics, 5; A. A. Shah, None; V. K. Shanmugam, None; V. D. Steen, None; T. M. Frech, None.

To cite this abstract in AMA style:

Gordon JK, Zhang M, Assassi S, Bernstein EJ, Domsic RT, Hant FN, Hinchcliff ME, Khanna D, Shah AA, Shanmugam VK, Steen VD, Frech TM. Interrater Reliability of Nailfold Capillaroscopy in Systemic Sclerosis Using Widefield Microscopy [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/interrater-reliability-of-nailfold-capillaroscopy-in-systemic-sclerosis-using-widefield-microscopy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interrater-reliability-of-nailfold-capillaroscopy-in-systemic-sclerosis-using-widefield-microscopy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology